Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I results on IONIS-DMPK-2.5R for the treatment of myotonic dystrophy type 1

May 3, 2016

BAY-1436032 shows promising antitumor activity in vivo

May 2, 2016

Marathon Pharmaceuticals discloses phase III results of deflazacort and prednisone for DMD

May 2, 2016

EPI-743 improves CNS markers of oxidative stress and retinal function in PD

May 2, 2016

miR-873's effects on glycine N-methyltransferase can be targeted to reduce liver injury

May 2, 2016

Antitumor activity observed in RAS-mutant cancers in phase I study of BGB-283

May 2, 2016

MEG3 levels are increased in hypoxia-induced pulmonary hypertension

May 2, 2016

RSPO3 is a potential biomarker of cholangitis

May 2, 2016

Novel genetic variant may cause mitochondrial diseases

April 29, 2016

NVR-3-778 well tolerated and reduces HBV DNA in phase Ib trial

April 29, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...